293 related articles for article (PubMed ID: 31856847)
21. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
[TBL] [Abstract][Full Text] [Related]
22. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis.
Miyakawa H; Izumi N; Marumo F; Sato C
Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):91A-94A. PubMed ID: 8659700
[TBL] [Abstract][Full Text] [Related]
23. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
24. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.
Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC
J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
26. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes.
Zhu H; Wu J; Shen X
Scand J Gastroenterol; 2017 Feb; 52(2):209-215. PubMed ID: 27797287
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.
De Re V; Caggiari L; Talamini R; Crovatto M; De Vita S; Mazzaro C; Cannizzaro R; Dolcetti R; Boiocchi M
Hum Immunol; 2004 Nov; 65(11):1397-404. PubMed ID: 15556690
[TBL] [Abstract][Full Text] [Related]
29. Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma.
Chiu YT; Wong JK; Choi SW; Sze KM; Ho DW; Chan LK; Lee JM; Man K; Cherny S; Yang WL; Wong CM; Sham PC; Ng IO
J Hepatol; 2016 Jun; 64(6):1256-64. PubMed ID: 26867494
[TBL] [Abstract][Full Text] [Related]
30. Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
Seshachalam VP; Sekar K; Hui KM
J Gastroenterol Hepatol; 2018 Dec; 33(12):2037-2047. PubMed ID: 29672926
[TBL] [Abstract][Full Text] [Related]
31. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
32. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
[TBL] [Abstract][Full Text] [Related]
33. Identification of prognostic alternative splicing signatures in hepatitis B or/and C viruses related hepatocellular carcinoma.
Cai Y; Xia J; Wang N; Zhou H
Genomics; 2020 Sep; 112(5):3396-3406. PubMed ID: 32525024
[TBL] [Abstract][Full Text] [Related]
34. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.
Lee SY; Song KH; Koo I; Lee KH; Suh KS; Kim BY
Genomics; 2012 Jun; 99(6):347-54. PubMed ID: 22564472
[TBL] [Abstract][Full Text] [Related]
35. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
[TBL] [Abstract][Full Text] [Related]
36. HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.
Matsuzaki Y; Chiba T; Hadama T; Asaoka H; Doy M; Shoda J; Tanaka N; Kinoshita M
Cancer Lett; 1997 Oct; 119(1):53-61. PubMed ID: 18372522
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanism of hepatocarcinogenesis.
Sheu JC
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
[TBL] [Abstract][Full Text] [Related]
38. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
[TBL] [Abstract][Full Text] [Related]
39. Distinction immune genes of hepatitis-induced heptatocellular carcinoma.
Hu J; Gao DZ
Bioinformatics; 2012 Dec; 28(24):3191-4. PubMed ID: 23104883
[TBL] [Abstract][Full Text] [Related]
40. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
Lambert MP; Paliwal A; Vaissière T; Chemin I; Zoulim F; Tommasino M; Hainaut P; Sylla B; Scoazec JY; Tost J; Herceg Z
J Hepatol; 2011 Apr; 54(4):705-15. PubMed ID: 21146512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
